Articles On Telix Pharmaceuticals (ASX:TLX)

Melbourne-based radiation oncology business Telix Pharmaceuticals has made its first-ever profit after strong sales for its prostate cancer imaging agent.

MELBOURNE, Australia, Feb. 22, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the financial year ended 31 December 2023. All figures are in AUD$ unless otherwise stated.[1...

Of course, here at The Motley Fool we always recommend investors practise proper diversification to manage investment risk. But there's nothing wrong with fantasising about wild riches from a single ASX stock. It's just good, clean fun. Be...

It turned out to be a shaky, but still positive, start to the trading week for the S&P/ASX 200 Index (ASX: XJO) and most shares this Monday. By the close of trading tod...

When you're running your slide rule over S&P/ASX 200 Index (ASX: XJO) stocks to add to your portfolio, one metric to watch closely is the works it has in its pipeline. A strong pool of promising projects or products on the horizon shou...

If you're willing to put up with a little bit more risk than the average, there are some ASX stocks out there with the capability to rocket in a short amount of time. They potentially have some catalysts coming that, if they occur, could p...

ASX gained ground as the S&P 500 reached record highs AI mania continues as Arm Ltd surges 20pc after hours AGL Energy jumps on huge H1, News Corp surprises   The ASX 200 gained +0.3% on Thursday, tracking its counterparts in New York...

The ASX200 is set to trade flattish today with a mixed night on Wall Street, itself currently absorbing myriad big-name financial earnings updates. ASX200 futures were up 0.04 per cent near 8:30 am AEDT. It’s that time of year where b...

It's been a kind end to the November trading month for ASX investors today, with the S&P/ASX 200 Index (ASX: XJO) shaking off some early jitters...

MELBOURNE, Australia, Nov. 30, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that the completed Phase II OPALESCENCE investigator-initiated trial (IIT) of its carbonic anhydrase IX (CAIX)-...

I discussed earlier this month how it took a while for Tesla Inc (NASDAQ: TSLA) to become a brand name synonymous with the entire electric vehicle industry. Those investors courageous enough to buy split-adjusted US$1.13 shares at the init...

Sure, a million bucks no longer gets you an average house in Sydney. But becoming a millionaire still has a ring to it, right? The fact is you can still do plenty with a cool mill in the bank — not least retire on a comfortable lifestyle....

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.13% to 7,049.40. A muted finish to the week with winners and losers split fairly evenly on the ASX200....

The S&P/ASX 200 Index (ASX: XJO) has given investors a bit of a lacklustre finish to the trading week this Friday, recording a slight loss as we head in...

The Australian stock market concluded the trading session on a positive note on Tuesday, propelled by a resurgence in commodity prices, with anticipation building around the forthcoming US inflation update. The ASX200 index surged by 0.8%,...

The ASX200 has added .83 per cent today… fuelled largely by the energy sector which rallied more than 2.5 per cent and materials, IT, real estate and industrials also added at least a per cent. Utilities fell the hardest today, giving up...

ASX lifted on the back of commodities rally overnight Most energy and mining stocks rose Telstra down after update, mining services stock ALQ was best performer   The ASX climbed +0.9% on Tuesday on the back of a rebound in commodity pric...

Telix Pharmaceuticals (ASX:TLX) is set to acquire a private US company QSAM Biosciences develops bone cancer treatments CycloSam, AKA Samarium-153-DOTMP, is QSAM’s lead asset A therapeutic radiopharmaceutical, the treatment is fa...

Telix Pharmaceuticals (ASX:TLX) has announced that the first patient has been dosed in its Phase 3 ProstACT GLOBAL study of its investigational prostate-specific membrane antigen targeting radio-antibody drug conjugate therapy, TLX5...

MELBOURNE, Australia, Nov. 14, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a conditional Term Sheet to acquire QSAM Biosciences, Inc. (QSAM) and its lead asset, CycloSam®...

MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Paris-based Mauna Kea Technologies (Euronext Growth: ALMKT, Mauna Kea), today announce an expansion of the IRiS...

MELBOURNE, Australia, Nov. 13, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company’s Phase III ProstACT GLOBAL study of its investigational...

MELBOURNE, Australia, Nov. 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement with Denmark-based WIIK Pharma ApS (Wiik Pharma) for the distribution of...

Shares higher after US Fed’s decision to keep rates steady Rates-sensitive stocks, like Tech and Real Estate, rallied Origin Energy slumped after AustralianSuper rejected consortium’s bid   The ASX rose by almost 1% on Thursday, driven by...

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

It was another negative day, if only just, for the S&P/ASX 200 Index (ASX: XJO) and ASX shares this Wednesday. After investors enjoyed a reprieve from the recent selli...

There's no need to wait for the Boxing Day sales to pick up some mega stocktake bargains. Plenty of quality ASX companies have already had their prices slashed over the past few months of share market volatility. But while everyone loves...

Telix Pharmaceuticals has seen a 25% drop in its share price in the past four days as the market turns on the ASX's second-largest biotechnology company. Let's explore why. The post TELIX’s [ASX:TLX] Gains in the Year Halved as Sell-Off Co...

The wall of worry continues to pressure the Australian share market with the escalating conflict sending both the S&P/ASX200 (INDEXASX: XJO) share price and All Ordinaries (INDEXASX: XAO) share price more than 1% on Thursday. Falling 1....

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.36% to 6981.60. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotif...

The ASX200 has fallen more than 1.3 per cent today to sit well below the 7000 point mark and all 11 sectors firmly in the red. In the green But let’s look at the high achievers first… Whitebark Energy (ASX:WBE) added 47 per cent of...

Australia’s latest labour force data has dropped and employment remains historically strong with unemployment at 3.6 per cent last month – slightly lower than in August. Another 23,000 people were employed, although the participation rat...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is getting punished today as investors respond to quarterly results and trial findings. In afternoon trade, shares in the radiopharmaceuticals company are positioned 11.7% lower at $9.0...

Last night's trading on the United States markets saw something rather incredible happen with the Netflix Inc (NASDAQ: NFLX) share price. It was a tough night for most of the US markets last night (our time). America's Wednesday session sa...

The S&P/ASX 200 Index (ASX: XJO) is having a day to forget on Thursday. In afternoon trade, the benchmark index is down a disappointing 1.3% to 6,986.1 points. Four ASX shares that are falling more than most today are listed below. He...

Telix Pharma down 17pc despite showing positive Q3 growth metrics Emyria to import MDMA to Australia after approval in Canada Vitura Health and Microba acquired new assets   Telix tumbles -17pc Telix Pharma (ASX:TLX) tumbled -17% this mor...

Telix (ASX:TLX) shareholders are likely today putting their phones down and walking away from the table as the company’s share price tumbles more than 15 per cent in early afternoon trade The stock dove below the line in tandem with the...

On Wednesday, the S&P/ASX 200 Index (ASX: XJO) was on form again and recorded a decent gain. The benchmark rose 0.3% to 7,077.6 points. Will the market be able to build on this on Thursday? Here are five things to watch: ASX 200 expe...

MELBOURNE, Australia, Oct. 18, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended 30 September...

A passive income of $200 each week for the rest of your life would be pretty handy for most Australians, but it's not such an outlandish dream. In fact, it's very achievable if you can commit to chipping in just $5 each day. That's the pri...

MELBOURNE, Australia and LIEGE, Belgium, Sept. 27, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) has welcomed Her Royal Highness, Princess Astrid, Princess of Belgium to Telix Manufacturing Solutions (T...

If you're already reading The Motley Fool, then you already have some idea that ASX growth shares are capable of bringing extraordinary riches. But there's nothing like cold hard numbers to demonstrate that power. How would you feel about...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Fancy having a million dollars to your name? Even though there is only a $5 difference between having $999,995 and having a seven-figure amount in your bank account, there is something about the title of "a millionaire" that continues to f...

Fancy having a million dollars to your name? Even though there is only a $5 difference between having $999,995 and having a seven-figure amount in your bank account, there is something about the title of "a millionaire" that continues to f...

According to the World Health Organisation (WHO), cancer is the leading cause of death globally. WHO defines cancer as a generic term for a large group of diseases that can affect any part of the body with malignant tumours and neoplasms. W...

The radiopharmaceuticals outfit’s market valuation has been irradiated since it raised a record $92 million and listed just over two years ago. Meanwhile, its bigger and wildly successful peer Telix Pharmaceuticals hogs the investor limelig...

It's been a happy end to the trading week indeed for the S&P/ASX 200 Index (ASX: XJO) and ASX shares this Friday. After having a fairly bumpy week, the ASX 200 went out in style today, recordi...

The S&P/ASX 200 Index (ASX: XJO) had another shaky day on Tuesday. Yesterday seemed to show that investors couldn't decide what they wanted out of the markets, with stints on both positive and ne...

It has been another busy week for Australia's top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these...